Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vomeronasal 1 receptor 17 pseudogene (VN1R17P) is a genomic locus in humans annotated as a pseudogene from the vomeronasal receptor family, historically associated with pheromone detection in other mammals. Although it shows sequence similarity to G protein-coupled receptors (GPCRs), specifically those related to the vomeronasal organ and pheromone sensing, it is classified as a pseudogene and does not encode a functional protein product in humans. Predicted activities—such as pheromone receptor function or participation in GPCR pathways—are inferred from sequence analysis, but not confirmed or active in the human genome. No drugs, disease associations, or biomarkers pertain to this gene, and there is no evidence that it is therapeutically relevant in humans[3][4].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal 1 receptor 17 pseudogene (VN1R17P).